Company / Profit Margin
ARS Pharmaceuticals, Inc. Profit Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-203.3%
FY2025
5-year range
-181216.7% / 9.0%
FY2022-FY2025
Trend
-2365.9%
vs FY2024
Sector context
#110 of 146
Health Care
What the data says
Profit Margin changed -2366% YoY in FY2025, a notable deviation from the 3-year average annual change of -17152%.
Based on SEC 10-K filings.
-203.3% in FY2025 with a 3-year CAGR of +164.4%.
Improved from -181216.7% to -203.3% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +164.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 146This company -203.3% Sector average -796.3%
▼
+74.5% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 2365.9% year-over-year.
- Currently 593.0pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -203.3% | -2365.9% |
| FY2024 | 9.0% | +100.0% |
| FY2023 | -181216.7% | -49190.5% |
| FY2022 | -367.6% | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026